Next Article in Journal
18F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
Next Article in Special Issue
Macrovascular Networks on Contrast-Enhanced Magnetic Resonance Imaging Improves Survival Prediction in Newly Diagnosed Glioblastoma
Previous Article in Journal
Modulation of RAB7A Protein Expression Determines Resistance to Cisplatin through Late Endocytic Pathway Impairment and Extracellular Vesicular Secretion
Previous Article in Special Issue
Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Cancers 2019, 11(1), 53; https://doi.org/10.3390/cancers11010053

Prognostic Gene Discovery in Glioblastoma Patients using Deep Learning

1
Department of Systems Medicine and Bioengineering, Houston Methodist, Houston, TX 77030, USA
2
Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA
3
Department of Radiology, Weill Cornell Medicine, New York, NY 10065, USA
4
Department of Neurosurgery, Houston Methodist Neurological Institute, Houston, TX 77030, USA
5
Department of Neuroscience, Weill Cornell Medicine, New York, NY 10065, USA
6
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA
*
Author to whom correspondence should be addressed.
Received: 14 November 2018 / Revised: 16 December 2018 / Accepted: 24 December 2018 / Published: 8 January 2019
(This article belongs to the Special Issue Glioblastoma: State of the Art and Future Perspectives)
  |  
PDF [702 KB, uploaded 8 January 2019]
  |     |  

Abstract

This study aims to discover genes with prognostic potential for glioblastoma (GBM) patients’ survival in a patient group that has gone through standard of care treatments including surgeries and chemotherapies, using tumor gene expression at initial diagnosis before treatment. The Cancer Genome Atlas (TCGA) GBM gene expression data are used as inputs to build a deep multilayer perceptron network to predict patient survival risk using partial likelihood as loss function. Genes that are important to the model are identified by the input permutation method. Univariate and multivariate Cox survival models are used to assess the predictive value of deep learned features in addition to clinical, mutation, and methylation factors. The prediction performance of the deep learning method was compared to other machine learning methods including the ridge, adaptive Lasso, and elastic net Cox regression models. Twenty-seven deep-learned features are extracted through deep learning to predict overall survival. The top 10 ranked genes with the highest impact on these features are related to glioblastoma stem cells, stem cell niche environment, and treatment resistance mechanisms, including POSTN, TNR, BCAN, GAD1, TMSB15B, SCG3, PLA2G2A, NNMT, CHI3L1 and ELAVL4. View Full-Text
Keywords: deep learning; discovery; glioblastoma; glioblastoma stem cells; survival prediction deep learning; discovery; glioblastoma; glioblastoma stem cells; survival prediction
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Wong, K.K.; Rostomily, R.; Wong, S.T.C. Prognostic Gene Discovery in Glioblastoma Patients using Deep Learning. Cancers 2019, 11, 53.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top